Aprea Therapeutics, Inc. (APRE) stock declined over -1.08% intraday to trade at $0.9793 a share on NASDAQ. The stock opened with a gain of 2.01% at $1 and touched an intraday high of $1.16, falling -1.08% against the last close of $0.99. The stock went to a low of $0.971 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company's lead product candidate is APR-246 (Eprenetapopt), a small molecule p53 reactivator that is in late-stage clinical development for the treatment of hematologic malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia, as well as for relapsed/refractory TP53 mutant chronic lymphoid leukemia; and gastric, bladder, and non-small cell lung cancers. It also develops APR-548, a p53 reactivator that is on Phase I dose-escalation clinical trial for oral administration in MDS patients. The company was founded in 2006 and is headquartered in Boston, Massachusetts.
Aprea Therapeutics, Inc. (NASDAQ: APRE) stock price is $0.9793 as of the last check on Monday, August 8. During the trading session, APRE stock reached the peak price of $1.16 while $0.971 was the lowest point it dropped to.
The NASDAQ listed APRE is part of Biotechnology industry that operates in the broader Health Care sector. Aprea Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes cancer therapeutics that reactivate mutant p53 tumor suppressor protein.
Mr. Christian S. Schade
Pres, CEO & Chairman
Mr. Scott M. Coiante
Sr. VP, Company Sec. & CFO
Dr. Eyal C. Attar M.D.
Sr. VP & Chief Medical Officer
Dr. Lars B. Abrahmsen
Sr. VP & Chief Scientific Officer
APRE stock traded closed the last session at $0.979, which is -$0.010700000000000043 or -1.080808080808085% lower than its previous close of $0.99. APRE's current trading price is 57.95% lower than its 52-week high of $5.67 where as its distance from 52-week low of 0.62% is -82.73%.
Number of APRE employees currently stands at -. APRE operates from 535 Boylston Street, Boston, MA 02116, United States.
Official Webiste of $APRE is: https://www.aprea.com
APRE stock volume for the day was 341,300 shares while in the previous session number of APRE shares traded was 341,300 . The average number of APRE shares traded daily for last 3 months was 916.65 Thousands.
The percentage change in APRE stock occurred in the recent session was -1.080808080808085% while the dollar amount for the price change in APRE stock was -$0.010700000000000043.
In the recent session, the day high for APRE stock was $1.16 while the low for APRE stock touched on the day was $0.971.
The market value of APRE currently stands at 21.96 Million with its latest stock price at $0.9793 and 21.9 Million of its shares outstanding.